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2Abstract. Background: One of the most important resistance mechanisms in bacteria
is the increased expression of multidrug efflux pumps. To combat efflux related
resistance, the development of new efflux pump inhibitors is essential. Materials and
Methods: Ten phosphorus ylides were compared based on their MDR-reverting
activity in multidrug efflux pump system consisting of the subunits acrA and acrB or
acridine resistance proteins A and B and the multidrug efflux pump subunit TolC or
outer membrane factor TolC (AcrAB-TolC) of Escherichia coli K-12 AG100 strain and
its AcrAB-TolC-deleted strain. Efflux inhibition was assessed by real-time fluorimetry
and the inhibition of quorum sensing (QS) was also investigated. The relative gene
expression of efflux QS genes was determined by real-time reverse transcriptase
quantitative polymerase chain reaction. Results: The most potent derivative was
Ph3P=C(COC2F5)CHO and its effect was more pronounced on the AcrAB-TolC-
expressing E. coli strain, furthermore the most active compounds,
Ph3P=C(COCF3)OMe, Ph3P=C(COC2F5)CHO and Ph3P=C(COCF3)COMe, reduced
the expression of efflux pump and QS genes. Conclusion: Phosphorus ylides might
be valuable EPI compounds to reverse efflux related MDR in bacteria.
Key Words: Phosphorus ylides, multidrug resistance, bacterial AcrAB-TolC, efflux
pump, quorum sensing.
3Multidrug resistance (MDR) is a serious problem for the treatment of various
diseases, such as bacterial and fungal infections and cancer, due to the reduction or
lack response of microorganisms as well as cancer cells to applied chemotherapeutic
agents (1,2).
One of the major mechanisms of MDR is the overexpression of efflux pumps
(EPs), which reduces the accumulation of toxic agents. In bacteria the resistance
nodulation division (RND) transporters have a great impact on MDR phenotype. The
major cause for the MDR phenotype is due to overexpresseion of efflux pumps that
are part of the RND family of transporters, for example the AcrAB-TolC system (1).
These efflux pumps have the ability to recognize and extrude a large variety of
unrelated antibiotics from the periplasmic space of the cell envelope, or from the
cytoplasm. The energy required for the operation of the efflux pump is provided by
the proton motive force created by the proton gradient resulting from electron
transport (3).
The quorum-sensing system (QS) in bacteria is a regulatory system that
controls gene expression depending on the density of the bacterial cell population. A
transcriptional regulator (LuxR homolog), signal synthase (LuxI homologue) and
autoinducer (acyl homoserine lactone) are crucial for the QS in most Gram-negative
bacteria. SdiA, an E. coli LuxR homolog, has a great impact on the colonization of E.
coli (4, 5). SdiA is a homolog of QS regulators that detects N-acylhomoserine lactone
(AHL) signals from other bacteria. SdiA represses the expression of virulence factors
by interacting with unknown stationary-phase signals in E. coli O157:H7, and
enhances multidrug resistance by activating MDR efflux pumps in E. coli (6).
4Organic compounds of phosphorus ylides (P-ylides) are a fascinating class of
compounds (7). The biological activity of P-ylides related to their ATP Binding
Cassette Subfamily B Member 1 (ABCB1)-modulating activity in mouse lymphoma
cells has already been described (8), however, additional information is needed to
describe their valuable biological activities in other aspects.
In this article, we report the MDR-modulating activities of P-ylides in bacteria related
to the inhibition of efflux activity and QS.
Materials and Methods
Compounds. The synthesis of P-ylides was described previously (8) and the
structures of the P-ylides (compounds 1-10) screened for their MDR-modulating
activities are shown in Table I. The compounds were dissolved in dimethyl sulfoxide
(DMSO) for the experiments.
Acridine orange (AO), ethidium bromide (EB), and LB broth were purchased
from Sigma-Aldrich Chemie GmbH (Steinheim, Germany). Modified LB agar (LB*)
contained 5 g yeast extract 10 g, trypton, 10 g NaCl, 1 g K2HPO4, 0.3 g MgSO4.7H2O
and 36 mg FeNaEDTA in 1.0 l of distilled water. Mueller Hinton broth was purchased
from Scharlau Chemie S.A. (Barcelona, Spain).
Bacterial strains. Wild-type E. coli K-12 AG100 strain [argE3 thi-1 rpsL xyl mtl Δ(gal-
uvrB) supE44]  expressing the AcrAB-TolC EP at its basal level and its AcrAB-TolC-
deleted mutant strain (E. coli K-12 AG100A).  The strains were kindly provided by
Professor Dr. Hiroshi Nikaido (Department of Molecular and Cell Biology and
Chemistry, University of California, Berkeley, CA, USA).
5Strains used for QS tests: Chromobacterium violaceum 026 (CV026) as
sensor strain; Sphingomonas spp. EZF 10-17 (Sphingomonadaceae) isolated from a
grapevine crown gall tumor (used as AHL producer), this strain induced pigment
production by CV026 and proved to be efficient for the study of QS interactions;
Enterobacter cloaceae 31298 (clinical wound isolate, used as AHL producer).
Determination of minimum inhibitory concentrations. The minimum inhibitory
concentrations (MICs) of P-ylides were tested according to Clinical and Laboratory
Standard Institute guidelines (9).
Real-time accumulation assay by Roche LightCycler real-time thermocycler. The
effect of the studied compounds on the real-time accumulation of EB was assessed
by an automated EB method (10), using a LightCycler real-time thermocycler
(LightCycler 1.5; Roche, Indianapolis, IN, USA).  Briefly, an aliquot of an overnight
culture of the strain in LB medium was transferred to fresh LB medium and incubated
until it reached an optical density (OD) of 0.6 at 600 nm. It was then washed with
phosphate-buffered saline (PBS; pH 7.4) and centrifuged at 13 000 × g for 3 min, the
pellets re-suspended in PBS (pH 7.4) and the OD adjusted to 0.6 at 600 nm.  The
compounds were added individually at different concentrations (in double
concentrated form) in 5 μl volumes of their stock solutions to 45 μl of EB solution of 2
mg/ l in PBS.  Then, 10 μl of the EB solution containing the compound were
transferred into standard glass capillary tubes of 20 µl maximum volume (Roche) and
10 μl of bacterial suspension (OD of 0.6 at 600 nm) was added to the capillaries.
The capillaries containing the samples were placed into a carousel (Roche) and the
fluorescence was monitored at the FL-2 channel every minute on a real-time basis.
6From the real-time data, the activity of the compound, namely the relative
fluorescence index (RFI) of the last time point (minute 30) of the EB accumulation
assay was calculated according to the formula:
where RFtreated is the relative fluorescence at the last time point of the EB retention
curve in the presence of an inhibitor, and RFuntreated is the relative fluorescence at the
last time point of the EB retention curve of the untreated solvent control (DMSO).
Assay for QS inhibition. LB* was used for these experiments. The sensor strain C.
violaceum 026 (CV026) and the AHL producer strains EZF 10-17 Sphingomonas
spp. (Sphingomonadaceae) or E. cloaceae 31298 were inoculated as parallel lines
and incubated at room temperature (20°C) for 24-48 h. QS inhibition was monitored
by agar diffusion method. Filter paper discs (7.0 mm in diameter) were impregnated
with 10 μl of stock solutions of the compounds in DMSO (10 mg/ml in DMSO). The
discs were placed between the parallel lines of sensor and AHL producer strains on
the surface of the nutrient agar. The plates were incubated at room temperature for a
further 24-48 h and the interactions between the strains and compounds were
evaluated for the reduction in size of the zone of pigment production and the zone of
growth inhibition of the affected strains, in millimeters. AO was applied as positive
control (11).
Expression analyses of genes by real-time reverse transcriptase quantitative
polymerase chain (RT-qPCR) reaction. Bacteria were cultured in LB broth and were
incubated overnight at 37°C with shaking. On the day of RNA isolation, the bacterial
untreated
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7suspensions (OD of 0.6 at 600 nm) were transferred to 10 ml tubes in 3 ml aliquots
and 50 µg/ml of compounds were added to the tubes which were the incubated at
37ºC. At intervals of 4 and 18 h of culture, the tubes were centrifuged at 12,000 × g
for 2 min. Pellets were suspended in 100 µl TE buffer containing 1 mg/ml lysozyme
by vigorous vortexing and were incubated at 37°C for 10 min. The total RNA was
isolated in an RNase-free environment using NucleoSpin RNA kit (Macherey Nagel,
Germany) according to the manufacturer’s instructions. Purified RNA was stored in
RNase-free water in nuclease-free collection tubes and was maintained at −20ºC
until quantification was performed. The concentration of the extracted RNA templates
was assessed by spectrophotometry at 260 nm.
Expression of the genes of the acridine resistance protein A (acrA), acridine
resistance protein B (acrB), multiple antibiotic resistance protein R (marR) and
quorum-sensing transcriptional activator (sdiA) genes was studied by reverse
transcription of total RNA. The data obtained for gene targets were normalized
against the E. coli house-keeping gene glyceraldehide-3-phosphate-dehydrogenase
(gapdh) measured in the same sample. Real-time quantification of the RNA
templates by real-time one-step RT-qPCR was performed in a CFX96 Touch real-
time PCR detection system (Bio-Rad, Hercules, CA, USA) strictly adhering to the
manufacturer recommendations of the SensiFASTTM SYBR No-ROX One-Step Kit
(Bioline GmbH, Luckenwalde, Germany). Briefly, each well of 96-well microtiter
plates contained, in a final volume of 20 µl, 10 µl of the 2x SensiFASTTM SYBR No-
ROX One-Step Mix, 0.2 µl Reverse Transcriptase, 0.4 µl RiboSafe RNase Inhibitor,
5.4 µl Diethylpyrocarbonate (DEPC)-treated water, 500 nM of each primer and
approximately 20 ng of total RNA in RNAase-free water. Thermal cycling was
8initiated with a denaturation step of 5 min at 95°C, followed by 40 cycles each of 10 s
at 95°C, 30 s at 57°C and 20 s at 72°C.
The forward and reverse primers used for assessment of the activity of the
transporter genes acrA, acrB, the regulator marR and the QS regulator sdiA are
shown in Table II.
Compounds 1-10 did not have any antibacterial effect on the AcrAB-TolC-expressing
E. coli AG100 (MDR) strain nor its AcrAB-TolC-deleted progeny E. coli AG100A (EP-
deleted strain) (MIC above 100 µg/ml), except for 6, which had a mild, non-significant
effect on the EP-deleted strain (MIC=50 μg/ml).
The activity of the compounds was compared based on the relative final
fluorescence index (RFI) of the real-time accumulation curves (Table III).
In the case of real-time EB accumulation by Light Cycler thermocycler, the
amount of EB accumulated by cells is higher if the difference between RFtreated and
RFuntreated is greater, therefore, the degree of inhibition of the EP system by the
compound becomes greater.
The majority of the P-ylides were found to inhibit the AcrAB-TolC system of E.
coli except Ph3P=C(COCF3)COPh (3), Ph3P=C(COC2F5)COPh (7) and
Ph3P=C(COC3F7)COPh (8), with had little or no effect on the intracellular EB
accumulation in the E. coli AG100 and the AG100A strains.  Among the P-ylide
series, Ph3P=C(COCF3)OMe (2), Ph3P=C(COCF3)CHO (4) and
Ph3P=C(COCF3)COMe (5) exhibited strong AcrAB-TolC pump-inhibiting properties
compared to the AcrAB-TolC pump-deficient mutant strain.  The most potent
derivative was 4 and its effect was more pronounced on the MDR E. coli strain
compared to the pump-deleted E. coli strain. This activity suggests that the
9compound may interfere with the proton motive force because AcrB utilizes proton
motive force as energy for its transport function.
The P-ylides were not able to inhibit the QS in the applied systems compared
to the positive control AO (data not shown).
Regarding the effect of P-ylides on the relative expression of efflux pump and
QS genes in E. coli AG100, the most effective compounds 2, 4, and 5 were selected
for gene-expression studies. In the assay, the gene of the multidrug efflux pump
subunit AcrB, the gene of the periplasmic AcrA subunit, the component of the E. coli
mar locus (multiple antibiotic resistance), and the gene of the LuxR homologue SdiA
were investigated. As shown in Figure 1A, compound 2 at 50 µg/ml up-regulated all
the genes studied after 4 h of exposure, however, after 18 h, the gene expression
returned to basal levels. Compound 4 also significantly up-regulated the secondary
RND transporter gene acrB (approximately 2-fold increase) after 4 h and 18 h
exposures as well. Surprisingly, there was up-regulation of sdiA expression after 18 h
compared to the expression level after 4 h implicating the ability of compound 2 to
influence the QS gene sdiA, however, this increase was not significant (Figure 1B).
Compound 5 up-regulated the expression levels of acrA and acrB after 4 h, although
after 18 h, the up-regulation of these genes was not significant (less than 2-fold
increase) as presented by Figure 1C.
Discussion
Some phenothiazines and hydantoins are known to be EPIs against both bacteria
and cancer cells (13). However, P-ylides 3, 7 and 8 have been shown to have activity
against the EPs of cancer cells (8), but not to have activity against the EP of bacteria.
It is important to note that ABC transporters are primary efflux pumps deriving their
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energy from the hydrolysis of ATP, however, the AcrAB-TolC system is a three-
component proton motive force-dependent multidrug efflux system. The most
effective compounds in the present bacterial system were compounds 2, 4, and 5,
which inhibi ted the AcrAB-TolC system and influenced the expression of the genes
acrA and acrB, which are constituents of the AcrAB-TolC system. In addition,
although the compounds are not QS inhibitors, compound 4 did increase the
expression of sdiA after 18 h exposure.
It can be concluded that in the COCF3 series (compounds 1-6),  the MDR-
reverting activity in the MDR E. coli strain was intensified in the following order: CHO
(4) > OMe (2), COMe (5) >> CO2Et (6), COPh (3), CN (1).
Thus, some structurally related trifluoroacetylated P-ylides differ in their MDR-
reversal activities between cancer cells and bacterial strains, indicating that the
compounds differently act as inhibitors of primary (ABCB1) and secondary (AcrB)
efflux pumps because these pumps differ in their energy source for driving the pump
(ATP and PMF, respectively).
The present study demonstrated that trifluoroacetylated P-ylides may be
attractive lead EPIs for further development as a MDR-reversing agents, however,
their mode of action should be elucidated by structure–activity relationship studies.
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Table I. Structures of P-ylides (compounds 1-10)
Ph3P
R1
R2
Ph3P
H
R2
R12O
1-9
Compound R1 R2
1 COCF3 CN
2 COCF3 OMe
3 COCF3 COPh
4 COCF3 CHO
5 COCF3 COMe
6 COCF3 CO2Et
7 COC2F5 COPh
8 COC3F7 COPh
9 COCH3 CN
10 H CN
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Table II. Forward and reverse primers used for assessment of the activity of the
transporter genes acrA and acrB, the regulator marR and the quorum-sensing
regulator sdiA of Escherichia coli AG100.
Gene Full name Primer sequence ( 5’-3’) Amplicon
size (bp)
Reference
acrA Acridine
resistance
protein A
CTTAGCCCTAACAGGATGTG
TTGAAATTACGCTTCAGGAT
189 (12)
acrB Acridine
resistance
protein B
CGTACACAGAAAGTGCTCAA
CGCTTCAACTTTGTTTTCTT
183 (12)
marR Multiple
antibiotic
resistance
protein R
AGCGATCTGTTCAATGAAAT
TTCAGTTCAACCGGAGTAAT
170 (12)
sdiA Quorum-
sensing
transcriptional
activator
CTGATGGCTCTGATGCGTTTA
TCTGGTGGAAATTGACCGTATT
163 This
study
gapdh Glyceraldehyde-
3-phospate
dehydrogenase
ACTTACGAGCAGATCAAAGC
AGTTTCACGAAGTTGTCGTT
170 (12)
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Table III. Relative final fluorescence index (RFI) for the affect of P-ylides (compounds
1-10) on the AcrAB-TolC-expressing Escherichia coli AG100 and pump-deleted E.
coli AG100A strains at 50 µg/ml
RFIaCompound
AG100 AG100A
1 0.36 0.46
2 0.64 0.49
3 0.04 0.12
4 0.73 0.46
5 0.42 0.27
6 0.25 0.49
7 0.02 0
8 0 0.19
9 0.29 0.32
10 0.42 0.44
a RFI was calculated according to the formula:
 where RFtreated is the relative fluorescence at the last point (30 min) of  the ethidium
bromide (EB) retention curve in the presence an P-ylide and RFuntreated is the relative
fluorescence  at the last point (30 min) of  the EB retention curve of the untreated
solvent control dimethyl sulfoxide (DMSO).
untreated
untreatedtreated
RF
RFRFRFI −=
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Figure 1. Relative gene expression levels of the genes of the acridine resistance
protein A (acrA), acridine resistance protein B (acrB), multiple antibiotic resistance
protein R (marR) and quorum-sensing transcriptional activator (sdiA) in the presence
of compounds 2 (A), 4 (B), and 5 (C) after 4 and 18 h exposure in LB. The line
denotes a threshold value, which was set at a two-fold increase in transcripts.
